Jialei Weng

机构：National Instruments (Ireland), Sir Run Run Shaw Hospital, Zhejiang University · ORCID：0000-0002-4916-0799

发表论文 80 篇 · 总被引 1080 次 · h-index 17

代表论文

• AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization (2024 · Journal for ImmunoTherapy of Cancer · 被引 30)
• FMO2 + cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 22)
• Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers (2025 · Journal of Experimental & Clinical Cancer Research · 被引 14)
• AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5 (2025 · Cell Death and Disease · 被引 11)
• WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy (2024 · Journal for ImmunoTherapy of Cancer · 被引 11)
• Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma (2025 · Gut · 被引 10)